Serum CA125, CA199, estradiol, FSH, IL-6, TNF-a in endometriosis after administration of Tripterygium wilfordii glycosides
Background: To evaluate the therapeutic effects of Tripterygium wilfordii glycosides on endometriosis (EMs) and their effects on serum sex hormone levels, tumour markers, and inflammatory factors (serum CA125, CA199, Estradiol, FSH, IL-6, TNF-a). Methods: A total of 108 patients were randomly divide...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Society of Medical Biochemists of Serbia, Belgrade
2025-01-01
|
| Series: | Journal of Medical Biochemistry |
| Subjects: | |
| Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2025/1452-82582504770X.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849425460637728768 |
|---|---|
| author | Xu Fangdan Xu Ying Qiu Jianping |
| author_facet | Xu Fangdan Xu Ying Qiu Jianping |
| author_sort | Xu Fangdan |
| collection | DOAJ |
| description | Background: To evaluate the therapeutic effects of Tripterygium wilfordii glycosides on endometriosis (EMs) and their effects on serum sex hormone levels, tumour markers, and inflammatory factors (serum CA125, CA199, Estradiol, FSH, IL-6, TNF-a). Methods: A total of 108 patients were randomly divided into control, progesterone, and Tripterygium wilfordii glycoside-treated groups, each receiving treatment for three months. The clinical efficacy and serum levels of estradiol, follicle-stimulating hormone, tumour markers (cancer antigen125 and cancer antigen199), and pro-inflammatory cytokines were compared before and after treatment. Results: The Tripterygium wilfordii glycoside group exhibited a significantly higher clinically effective rate (90.74% versus 75.93%) and more significant reductions in estradiol, follicle-stimulating hormone, cancer antigen125, cancer antigen199, IL-6, TNF-a, and HSCRP levels than the control group. Conclusions: Tripterygium glycosides exhibit significant clinical efficacy in treating patients with EMS by significantly improving serum sex hormone levels, reducing tumour marker levels, alleviating inflammatory reactions, and exerting minimal toxic side effects. |
| format | Article |
| id | doaj-art-a467e5bc45c04330b27a2c0d9a3ac8bb |
| institution | Kabale University |
| issn | 1452-8258 1452-8266 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Society of Medical Biochemists of Serbia, Belgrade |
| record_format | Article |
| series | Journal of Medical Biochemistry |
| spelling | doaj-art-a467e5bc45c04330b27a2c0d9a3ac8bb2025-08-20T03:29:44ZengSociety of Medical Biochemists of Serbia, BelgradeJournal of Medical Biochemistry1452-82581452-82662025-01-0144477077510.5937/jomb0-566321452-82582504770XSerum CA125, CA199, estradiol, FSH, IL-6, TNF-a in endometriosis after administration of Tripterygium wilfordii glycosidesXu Fangdan0Xu Ying1Qiu Jianping2The Affiliated Suzhou Hospital of Nanjing Medical University, Department of Obstetrics and Gynecology, Suzhou, Jiangsu Province, ChinaThe Affiliated Suzhou Hospital of Nanjing Medical University, Department of Obstetrics and Gynecology, Suzhou, Jiangsu Province, ChinaThe Affiliated Suzhou Hospital of Nanjing Medical University, Department of Obstetrics and Gynecology, Suzhou, Jiangsu Province, ChinaBackground: To evaluate the therapeutic effects of Tripterygium wilfordii glycosides on endometriosis (EMs) and their effects on serum sex hormone levels, tumour markers, and inflammatory factors (serum CA125, CA199, Estradiol, FSH, IL-6, TNF-a). Methods: A total of 108 patients were randomly divided into control, progesterone, and Tripterygium wilfordii glycoside-treated groups, each receiving treatment for three months. The clinical efficacy and serum levels of estradiol, follicle-stimulating hormone, tumour markers (cancer antigen125 and cancer antigen199), and pro-inflammatory cytokines were compared before and after treatment. Results: The Tripterygium wilfordii glycoside group exhibited a significantly higher clinically effective rate (90.74% versus 75.93%) and more significant reductions in estradiol, follicle-stimulating hormone, cancer antigen125, cancer antigen199, IL-6, TNF-a, and HSCRP levels than the control group. Conclusions: Tripterygium glycosides exhibit significant clinical efficacy in treating patients with EMS by significantly improving serum sex hormone levels, reducing tumour marker levels, alleviating inflammatory reactions, and exerting minimal toxic side effects.https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2025/1452-82582504770X.pdfserum ca125ca199estradiolfshil-6tnf-aendometriosisinflammatory factorserum sex hormonestherapeutic effecttripterygium wilfordii glycosidestumour markers |
| spellingShingle | Xu Fangdan Xu Ying Qiu Jianping Serum CA125, CA199, estradiol, FSH, IL-6, TNF-a in endometriosis after administration of Tripterygium wilfordii glycosides Journal of Medical Biochemistry serum ca125 ca199 estradiol fsh il-6 tnf-a endometriosis inflammatory factor serum sex hormones therapeutic effect tripterygium wilfordii glycosides tumour markers |
| title | Serum CA125, CA199, estradiol, FSH, IL-6, TNF-a in endometriosis after administration of Tripterygium wilfordii glycosides |
| title_full | Serum CA125, CA199, estradiol, FSH, IL-6, TNF-a in endometriosis after administration of Tripterygium wilfordii glycosides |
| title_fullStr | Serum CA125, CA199, estradiol, FSH, IL-6, TNF-a in endometriosis after administration of Tripterygium wilfordii glycosides |
| title_full_unstemmed | Serum CA125, CA199, estradiol, FSH, IL-6, TNF-a in endometriosis after administration of Tripterygium wilfordii glycosides |
| title_short | Serum CA125, CA199, estradiol, FSH, IL-6, TNF-a in endometriosis after administration of Tripterygium wilfordii glycosides |
| title_sort | serum ca125 ca199 estradiol fsh il 6 tnf a in endometriosis after administration of tripterygium wilfordii glycosides |
| topic | serum ca125 ca199 estradiol fsh il-6 tnf-a endometriosis inflammatory factor serum sex hormones therapeutic effect tripterygium wilfordii glycosides tumour markers |
| url | https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2025/1452-82582504770X.pdf |
| work_keys_str_mv | AT xufangdan serumca125ca199estradiolfshil6tnfainendometriosisafteradministrationoftripterygiumwilfordiiglycosides AT xuying serumca125ca199estradiolfshil6tnfainendometriosisafteradministrationoftripterygiumwilfordiiglycosides AT qiujianping serumca125ca199estradiolfshil6tnfainendometriosisafteradministrationoftripterygiumwilfordiiglycosides |